Loss of chondroitin 6- O -sulfotransferase-1 function results in severe human chondrodysplasia with progressive spinal involvement
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
We studied two large consanguineous families from Oman with a distinct form of spondyloepiphyseal dysplasia (SED Omani type). By using a genome-wide linkage approach, we were able to map the underlying gene to a 4.5-centimorgan interval on chromosome 10q23. We sequenced candidate genes from the region and identified a missense mutation in the chondroitin 6- O -sulfotransferase (C6ST-1) gene ( CHST3 ) changing an arginine into a glutamine (R304Q) in the well conserved 3′-phosphoadenosine 5′-phosphosulfate binding site. C6ST-1 catalyzes the modifying step of chondroitin sulfate (CS) synthesis by transferring sulfate to the C-6 position of the N -acetylgalactosamine of chondroitin. From the crystal structures of other sulfotransferases, it could be inferred that Arg-304 is essential for the structure of the cosubstrate binding site. We used recombinant C6ST-1 to show that the identified missense mutation completely abolishes C6ST-1 activity. Disaccharide composition analysis of CS chains by anion-exchange HPLC shows that both ΔHexA-GalNAc(6S) and ΔHexA(2S)-GalNAc(6S) were significantly reduced in the patient's cells and that ΔHexA-GalNAc(4S,6S), undetectable in controls, was elevated. Analysis of the patient's urine shows marked undersulfation of CS, in particular reduction in 6- O -sulfated disaccharide and an increase in the nonsulfated unit. Our results indicate that the mutation in CHST3 described here causes a specific but generalized defect of CS chain sulfation resulting in chondrodysplasia with major involvement of the spine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, complete deficiency of PAPSS2 causes spondyloepimetaphyseal dysplasia of the Pakistani type, but steroid metabolism was not assessed in this kindred, and women could not be studied at all (610).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [610]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed · Cited by 2,877
Easy calculations of lod scores and genetic risks on small computers.
Lathrop, M. G., & Lalouel, J.-M. (1984) · Europe PMC (PubMed Central) · Cited by 1,526
Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate
Sugahara, K., Mikami, T., Uyama, T., Mizuguchi, S., Nomura, K., & Kitagawa, H. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.09.011 · Cited by 694
Self-citationRecent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans
Sugahara, K., & Kitagawa, H. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00125-1 · Cited by 423
Self-citationSulfotransferases in glycosaminoglycan biosynthesis
Kusche-Gullberg, M. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.08.002 · Cited by 307
Akama, T. O., Nishida, K., Nakayama, J., Watanabe, H., Ozaki, K., Nakamura, T., Dota, A., Kawasaki, S., Inoue, Y., Maeda, N., et al. (2000) · Nature Genetics · doi:10.1038/79987 · Cited by 297
Kawashima, H., Atarashi, K., Hirose, M., Hirose, J., Yamada, S., Sugahara, K., & Miyasaka, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200396200 · Cited by 241
Self-citationMutations in orthologous genes in human spondyloepimetaphyseal dysplasia and the brachymorphic mouse
Haque, M. F. U., King, L. M., Krakow, D., Cantor, R. M., Rusiniak, M. E., Swank, R. T., Superti-Furga, A., Haque, S., Abbas, H., Ahmad, W., et al. (1998) · Nature Genetics · doi:10.1038/2458 · Cited by 217
Kinoshita, A., & Sugahara, K. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4027 · Cited by 213
Self-citationRossi, A., & Superti-Furga, A. (2001) · Human Mutation · doi:10.1002/humu.1 · Cited by 195
Research works printed but not linked: 3
- Lathrop, G. M. & Lalouel, J. M. (1984) Am. J. Hum. Genet. 36, 460-465. [PMC free article] [PubMed] [Google Scholar]
- Kruglyak, L., Daly, M. J., Reeve-Daly, M. P. & Lander, E. S. (1996) Am. J. Hum. Genet. 58, 1347-1363. [PMC free article] [PubMed] [Google Scholar]
- So, C. L., Kaluarachchi, K., Tam, P. P. & Cheah, K. S. (2001) Osteoarthritis Cartilage 9, Suppl. A, S160-S173. [PubMed] [Google Scholar]
Cited by
Items 101–190 of 190
Silveira, C., Leal, G. F., & Cavalcanti, D. P. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37858 · Cited by 25
“A number of genetic disorders are caused by mutations in genes related to PGs (B4GALT7, B3GALT6, B3GAT3, SLC26A2/DTDST, CHST3, and IMPAD1), and demonstrate a skeletal dysplasia with an important articular involvement [Hastbacka et al., 1994; Okajima et al., 1999; Thiele et al., 2004; Baasanjav et al., 2011; Vissers et…”
BackgroundCarbohydrate sulfotransferases: a review of emerging diagnostic and prognostic applications
Debeljak, Ž., Begolli, G., Marković, I., & Knežević, J. (2023) · Biochemia Medica · doi:10.11613/bm.2023.030503 · Cited by 30
Approaches to homozygosity mapping and exome sequencing for the identification of novel types of CDG
Matthijs, G., Rymen, D., Millón, M. B. B., Souche, E. L., & Race, V. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9445-7 · Cited by 21
“[13–17, 19–48, 53–76] 72 Glycoconj J (2013) 30:67–76”
Baidoe‐Ansah, D., Sakib, M. S., Jia, S., Mirzapourdelavar, H., Strackeljan, L., Fischer, A., Aleshin, S. E., Kaushik, R., & Dityatev, A. E. (2022) · Cells · doi:10.3390/cells11132033 · Cited by 16
“Findings from patients with skeletal abnormalities also showed additional cardiac abnormalities including valve regurgitations [19].”
BackgroundSorrell, J. M., Somoza, R. A., & Caplan, A. I. (2017) · Journal of Orthopaedic Research® · doi:10.1002/jor.23820 · Cited by 21
“The PRG4 gene codes for the PG core protein termed lubricin.(30) Lubricin is produced by synovial cells in mature joints.”
BackgroundSrivastava, P., Pandey, H., Agarwal, D., Mandal, K., & Phadke, S. R. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37996 · Cited by 16
Chondrodysplasias With Multiple Dislocations Caused by Defects in Glycosaminoglycan Synthesis
Dubail, J., & Cormier‐Daire, V. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.642097 · Cited by 25
“Furthermore, a reduction in 6-Osulfated disaccharides in patient urine was reported (Thiele et al., 2004).”
BackgroundAntia, I. U., Mathew, K., Yagnik, D. R., Hills, F. A., & Shah, A. J. (2017) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-017-0703-1 · Cited by 16
“Dysregulated GAG disaccharide composition is also seen in human chondrodysplasia [13].”
BackgroundReynard, L. N., Ratnayake, M., Santibanez‐Koref, M., & Loughlin, J. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159024 · Cited by 15
“Aberrant GAG sulfation can lead to a range of skeletal pathologies, including abnormal growth plate development, bone shortening and chondrodysplasia [37 – 39].”
Tanteles, G. A., Dixit, A., Dhar, S., & Suri, M. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36094 · Cited by 13
Haouari, W., Dubail, J., Poüs, C., Cormier‐Daire, V., & Bruneel, A. (2021) · Genes · doi:10.3390/genes12111654 · Cited by 15
“This technique showed decreased HS serum levels in EXTL3-deficient cases [88], while major hyposulfation of CS chains was detected in urine from one CHST3 mutated patient [89].”
BackgroundWang, W., Li, F., Wang, K., Cheng, B., & Guo, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043475 · Cited by 13
“Chondroitin 6-O-sulfotransferase requires PAPS for catalytic activity, and the abnormal PAPSS2 gene that encodes chondroitin 6-O-sulfotransferase can cause SEMD, Omani type [10].”
BackgroundEmerging tools to study proteoglycan function during skeletal development
Brown, D. S., & Eames, B. F. (2016) · Methods in cell biology · doi:10.1016/bs.mcb.2016.03.001 · Cited by 16
Chopra, S. S., Leshchiner, I., Duzkale, H., McLaughlin, H. M., Giovanni, M. A., Zhang, C., Stitziel, N. O., Fingeroth, J. D., Joyce, R., Lebo, M. S., et al. (2015) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.152 · Cited by 12
“Homozygous or compound heterozygous mutations in CHST3, encoding a chondroitin 6-sulfotransferase, are associated with recessive spondyloepiphyseal dysplasia and congenital joint dislocations (OMIM 143095) (Thiele et al. 2004; Unger et al. 2010).”
BackgroundChondroitin sulfate in tissue remodeling: Therapeutic implications for pulmonary fibrosis
Kai, Y., Yoneyama, H., Yoshikawa, M., Kimura, H., & Muro, S. (2021) · Respiratory Investigation · doi:10.1016/j.resinv.2021.05.012 · Cited by 12
Karousou, E. G., Asimakopoulou, A. P., Monti, L., Zafeiropoulou, V., Afratis, N. A., Gartaganis, P., Rossi, A., Passi, A. G., & Karamanos, N. K. (2014) · Molecules · doi:10.3390/molecules19067959 · Cited by 15
“Among them, spondyloepiphyseal dysplasia Omani type, a recessive chondrodysplasia with a defect in the macromolecular sulfation pathway, showed alteration of GAG sulfation in the urine of a patient [20].”
BackgroundKoike, T., Mikami, T., Tamura, J., & Kitagawa, H. (2022) · Nature Communications · doi:10.1038/s41467-022-35687-3 · Cited by 13
Self-citationNovel and recurrent COL2A1 mutations in Chinese patients with spondyloepiphyseal dysplasia
Cao, L. H., Wang, L., Ji, C. Y., Wang, L. B., Ma, H. W., & Luo, Y. (2012) · Genetics and Molecular Research · doi:10.4238/2012.september.27.1 · Cited by 11
McDonnell, E., Orr, S. E., Barter, M. J., Rux, D. R., Brumwell, A. L., Wrobel, N., Murphy, L., Overman, L. M., Sorial, A. K., Young, D. A., et al. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.10.017 · Cited by 12
“63 Any conferred changes to the expression of the gene and its encoded protein, mediated through differential methylation, could potentially confer a subtle phenotypic shift within cartilage, altering joint morphology, 64 or decreasing its integrity to withstand mechanical forces over the life…”
Yorifuji, K., Uemura, Y., Horibata, S., Tsuji, G., Suzuki, Y., Miyagawa, K., Nakayama, K., Hirata, K., Kumagai, S., & Emoto, N. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.08.011 · Cited by 10
Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis
Miyamoto, K., Tanaka, N., Moriguchi, K., Ueno, R., Kadomatsu, K., Kitagawa, H., & Kusunoki, S. (2014) · Glycobiology · doi:10.1093/glycob/cwu014 · Cited by 9
“abolish C6ST activity almost completely and cause severe human chondrodysplasia with major involvement of the spine (Thiele et al. 2004; van Roij et al. 2008).”
BackgroundSelf-citationKai, Y., Tomoda, K., Yoneyama, H., Yoshikawa, M., & Kimura, H. (2015) · Respiratory Research · doi:10.1186/s12931-015-0310-7 · Cited by 9
“In addition, mutation in CHST3 results in chondrodysplasia with major involvement of the spine [13].”
BackgroundKnockout Mice and Proteoglycans
Kimata, K., Habuchi, O., Habuchi, H., & Watanabe, H. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00087-8 · Cited by 15
Albuz, B., Çetin, G. O., Özhan, B., Sarıkepe, B., Anlaş, Ö., Öztürk, M., Zeybek, S., Sabir, N., Bağcı, G., & Gündüz, C. N. S. (2019) · Clinical Dysmorphology · doi:10.1097/mcd.0000000000000295 · Cited by 8
“SED-OT was first described phenotypically in nine patients from two families from Oman and by using a genome-wide linkage approach, mutations in the CHST3 gene were elucidated (Rajab et al., 2004; Thiele et al., 2004).”
BackgroundLim, P. J., Marfurt, S., Lindert, U., Opitz, L., Ndarugendamwo, T., Srikanthan, P., Poms, M., Hersberger, M., Langhans, C., Haas, D., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.662751 · Cited by 7
“Loss-of-function mutations in CHST3 are causative of spondyloepiphyseal dysplasia (SED) Omani type (OMIM 143095) (Thiele et al., 2004), in which a missense mutation in CHST3 leads to a generalized defect in the chain sulfation of chondroitin sulfate resulting in severe chondrodysplasia.”
BackgroundKausar, M., Ain, N. U., Hayat, F., Fatima, H., Azim, S., Ullah, H., Mushtaq, M., Khalid, S., Hussain, S., Naz, S., et al. (2022) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-022-05719-6 · Cited by 8
“The identified CHST3 variants c.603C > A;p.(Tyr201Ter) in affected individuals of family SND-17 and c.661C > T;p. (Arg221Cys) in NAD-05 patients have been previously reported in affected individuals of one Spanish and two unrelated Asian families with SED [9, 10].”
BackgroundInfluentialYang, M., Nakamura, M., Kageyama, Y., Igari, Y., & Sasano, Y. (2023) · Gerontology · doi:10.1159/000533921 · Cited by 8
Molecular Basis for the Biosynthesis of Oligo- and Polysaccharides
Wilson, I. B. H., Breton, C., Imberty, A., & Tvaroška, I. (2008) · Springer eBooks · doi:10.1007/978-3-540-30429-6_59 · Cited by 10
Robertson, S. P. (2013) · Cited by 7
Fan, L., He, Y., Han, J., Yuan, P.-W., Guo, X., & Wang, W. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6843 · Cited by 7
“SEMD of the Omani type is caused by deficient chondroitin 6-O-sulfotransferase activity due to an abnormal PAPSS2 gene that impairs PAPS biosynthesis (4,12).”
BackgroundArdıçlı, S., Yigitgor, P., Babayev, H., Özen, D., Bozkurt, B., Şentürk, N., Pilli, M., SALCI, H., & Intas, D. S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37716 · Cited by 6
“For instance, while the CHST3 gene is a prominent focus in human skeletal dysplasia studies [57 – 59], there is a notable absence of information concerning the interplay between this gene and its genomic region with elbow dysplasia in dogs.”
BackgroundRecurrent c.776T>C mutation in CHST3 with four other novel mutations and a literature review
Düz, M. B., & Topak, A. (2020) · Clinical Dysmorphology · doi:10.1097/mcd.0000000000000329 · Cited by 6
Osteoarthritis – Genetic Studies of Monogenic and Complex Forms
Valdes, A. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387829-8.00018-4 · Cited by 5
Modifications of Glycans and Glycoconjugates
Stick, R. V., & Williams, S. J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-240-52118-3.00010-7 · Cited by 5
The growth plate: Zonal architecture, plasticity, and endocrine control of linear growth
Barba‐Ostria, C., & Yakar, S. (2026) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2026.101679 · Cited by 11
Congenital Disorders of Glycosylation
Sosicka, P., Ng, B. G., & Freeze, H. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00013-4 · Cited by 5
CHST3-related skeletal dysplasia
INSERM (2020) · Definitions · doi:10.32388/ogmjba · Cited by 4
Packer, R. J., Coley, K., Williams, A. T., Shrine, N. R. G., Izquierdo, A. G., Chen, J., Batini, C., Marttila, M., Rao, B. S., Bratty, R., et al. (2025) · Pain · doi:10.1097/j.pain.0000000000003785 · Cited by 4
Otaify, G. A., Elhossini, R. M., Abdel‐Ghafar, S. F., Sayed, I. S. M., Abdel‐Salam, G. M. H., Aglan, M., & Abdel‐Hamid, M. S. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63246 · Cited by 5
“Deficiency of CHST3 was first described in a large Omani kindred with spondylo-epiphyseal dysplasia (Rajab et al., 2004; Thiele et al., 2004).”
BackgroundCarbohydrate sulfotransferases in glycosaminoglycan biosynthesis
Barone, D., Joshi, L., & Kilcoyne, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-819655-7.00013-8 · Cited by 5
Mikami, T., & Kitagawa, H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00018-3 · Cited by 4
Self-citationBerger, E. G., & Rohrer, J. (2009) · Springer eBooks · doi:10.1007/978-3-211-76310-0_12 · Cited by 3
Hannesson, K. O., Ytteborg, E., Takle, H., Enersen, G., Bæverfjord, G., & Pedersen, M. E. (2015) · Fish Physiology and Biochemistry · doi:10.1007/s10695-015-0067-4 · Cited by 3
“Severe progressive scoliosis preceded by diminished intervertebral discs and abnormal vertebral endplates, accompanied by severe arthritic changes with joint dislocations (Thiele et al. 2004).”
BackgroundBiomanufacturing of Therapeutically Relevant Chondroitin Sulfate C via Engineered Microbes
Tithi, A. D., Zeghal, H., Song, Y., Paskaleva, E. E., Vangaveti, S., & Koffas, M. A. G. (2026) · ACS Synthetic Biology · doi:10.1021/acssynbio.5c00780 · Cited by 2
Indian patients with CHST3 ‐related chondrodysplasia with congenital joint dislocations
Singh, S., Jacob, P., Patil, S. J., Muranjan, M. N., Shah, H. H., Girisha, K. M., & Bhavani, G. S. (2023) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.63422 · Cited by 3
“Chondroitin sulfate is a proteoglycan present in cartilage and distributed on the surface of most cells and extracellular matrices (Thiele et al., 2004).”
BackgroundCongenital disorders caused by aberrations in the biosynthesis of chondroitin/dermatan sulfate
Mikami, T., Mizumoto, S., Kitagawa, H., & Yamada, S. (2025) · Journal of Human Genetics · doi:10.1038/s10038-025-01396-0 · Cited by 5
Self-citationRajab, A. (2010) · Springer eBooks · doi:10.1007/978-3-642-05080-0_16 · Cited by 3
Self-citationChondrodysplasia of Texel sheep.
Sa, P. (2008) · Europe PMC (PubMed Central) · Cited by 2
Mughal, T. A., Asim, M., Gillani, S. H. U. H., Chughtai, N. O., Batool, S. A., Hussain, A., Shujaat, K., & Gilani, S. Z. T. (2024) · Molecular Syndromology · doi:10.1159/000538039 · Cited by 3
Wang, T., Liu, Z.-X., Gong, X., Shi, C.-Q., Cai, Y., Wang, F., & Sheng, J. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147941 · Cited by 1
Genome-Wide Comparative and Phylogenetic Analysis of Putative Algal Carbohydrate Sulfotransferases
Ho, C., Low, X.-Z., Lee, W.-K., & Bothwell, J. H. F. (2026) · Journal of Molecular Evolution · doi:10.1007/s00239-025-10299-9 · Cited by 1
“…to the C-6 position of different SPs i.e., N-acetylglucosamine (GlcNAc) and Gal of keratan and N-acetyl-galactosamine (GalNAc) of chondroitin (Thiele et al. 2004; Akama et al. 2001; Yeh et al. 2001; Kitagawa et al. 2000; Lee et al. 1999; Fukuta et al. 1997), it is plausible that brown algal…”
Habuchi, O. (2014) · Springer eBooks · doi:10.1007/978-4-431-54240-7_41 · Cited by 1
A Novel In-Frame Type Deletion in CHST3 Gene in A Patient with Spondyloepiphyseal Dysplasia
Çetin, B. V., Sipahioğlu, S., & GÜMÜŞ, E. (2022) · Harran Üniversitesi Tıp Fakültesi Dergisi · doi:10.35440/hutfd.1187444 · Cited by 1
A Chinese case of CHST3-related skeletal dysplasia and a systematic review
Liang, H., Qi, W., Jin, C., Pang, Q., Cui, L., Jiang, Y., Wang, O., Li, M., Xing, X., Liu, W., et al. (2023) · Endocrine · doi:10.1007/s12020-023-03303-z · Cited by 3
Sugahara, K., & Mizumoto, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-3381-1_3 · Cited by 1
“Moreover, CS structures containing C-, D-, and E-units in different combinations play distinct roles in bone development (Thiele et al. 2004 ; van Roij et al. 2008 ) , neuritogenesis (Nadanaka et al. 1998 ; Clement et al. 1998 ) , and viral infections (Uyama et al. 2006 ) , respectively.”
BackgroundSelf-citationMolecular Genetics of the Cartilage Collagenopathies
Lamandé, S. R., Cameron, T. L., Savarirayan, R., & Bateman, J. F. (2017) · Springer eBooks · doi:10.1007/978-3-319-45803-8_6 · Cited by 2
Freidin, M. B., Freidin, M. B., Tsepilov, Y. A., Tsepilov, Y. A., Palmere, M., Palmere, M., Karssen, L. C., Karssen, L. C., Suri, P., Suri, P., et al. (2020) · Ból · doi:10.5604/01.3001.0014.0235 · Cited by 2
Biological Functions of Iduronic Acid in Chondroitin/Dermatan Sulfate in Tumor and Brain Development
Thelin, M. A. (2012) · Lund University Publications (Lund University) · Cited by 1
Lachman, R. S. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-01931-6.50050-5 · Cited by 1
Schwartz, N. B. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0000623.pub3 · Cited by 1
Epigenetic mechanisms of osteoarthritis risk in human skeletal developmentPreprint
McDonnell, E., Orr, S. E., Barter, M. J., Rux, D. R., Brumwell, A. L., Wrobel, N., Murphy, L., Overman, L. M., Sorial, A. K., Young, D. A., et al. (2024) · medRxiv · doi:10.1101/2024.05.05.24306832 · Cited by 1
“Mutations in CHST3 lead to skeletal dysplasia, highlighting the important function of this protein in skeletogenesis 53 .”
BackgroundMolecular Genetics of Congenital Multiple Large Joint Dislocation
Robertson, S. P. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2169-0_3
“Biallelic mutations in CHST3 cause SED-CHST3 type [37, 38, 40, 41].”
BackgroundGrowth Plate and Cellular Growth
Chagin, A. S., Hagenäs, L., & Savendahl, L. S. (2006) · KARGER eBooks · doi:10.1159/000094105
“Mutations in the C4st1 gene have not yet been reported in humans, but mutations of chondroitin-6-sulfortransferase 1 (C6st1) are known to be associated with chondrodysplasia [17].”
BackgroundWang, W., & Yuan, P. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.02.234
Cartografía genética de las enfermedades óseas constitucionales
Cormier‐Daire, V. (2011) · EMC - Aparato Locomotor · doi:10.1016/s1286-935x(11)71034-6
Cartographie génétique des maladies osseuses constitutionnelles
Cormier‐Daire, V. (2011) · EMC - Appareil locomoteur · doi:10.1016/s0246-0521(11)48911-7
Mizumoto, S. (2018) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.1812.2j · Cited by 2
Osteoarthritis: Genetic Studies of Monogenic and Complex Forms
Valdes, A. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804182-6.00024-1
Glycans in Osseous Tissue and Articulation
Mikami, T., Kitagawa, H., & Iwasaki, N. (2019) · Springer eBooks · doi:10.1007/978-981-13-5856-2_13
Self-citationBiology of Proteoglycans and Associated Glycosaminoglycans
Salinas-Marín, R., Villanueva-Cabello, T. M., & Martínez-Duncker, I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00065-1
Cheung, K., To, M. K.-T., Ho, D. W., & Song, Y. (2015) · Springer eBooks · doi:10.1007/978-3-662-48284-1_2
Cheung, K., Ho, D. W., & Song, Y. (2010) · Springer eBooks · doi:10.1007/978-3-540-85207-0_4
Cartografía genética de las enfermedades óseas constitucionales
Marzin, P., & Cormier‐Daire, V. (2020) · EMC - Aparato Locomotor · doi:10.1016/s1286-935x(20)44108-5
Chen, H. (2016) · Springer eBooks · doi:10.1007/978-1-4614-6430-3_145-2
Chen, H. (2017) · Springer eBooks · doi:10.1007/978-1-4939-2401-1_145
Quantum chemical calculations of IR spectra of heparin disaccharide subunits
Monakhova, Y. B., Ilicheva, P. M., Fedotova, E. S., Musina, K. T., & Burmistrova, N. A. (2022) · Computational and Theoretical Chemistry · doi:10.1016/j.comptc.2022.113891
Skeletal Dysplasias Caused by Defects in Glycosaminoglycan Sulfation
Tota, C. G., Leone, A., Paganini, C., Khan, A., Rossi, A., & Superti‐Furga, A. (2024) · Biology of extracellular matrix · doi:10.1007/978-3-031-70835-0_6 · Cited by 1
Govers, B. M., Bakker, B., de Bruijne, M. J., Oosterhof, A., Versteeg, E. M. M., den Hollander, A. I., Keijser, S., Klevering, B. J., Daamen, W. F., & Kuppevelt, T. H. V. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110672
Mikami, T., Takenaka, H., Morita, T., & Kitagawa, H. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152713
Self-citationSyndecan - Regulation and Function of its Glycosaminoglycan Chains
Eriksson, A. (2013) · Uppsala University Publications (Uppsala University)
Osteoarthritis: genetic studies of monogenic and complex forms
Valdes, A. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13683-2.00010-4
Importance des glycosaminoglycanes de surface dans les phénomènes inflammatoires liés au cancer
Martinez, P. (2014) · theses.fr (ABES) · doi:10.70675/d8d46778ze3baz4df0z9270z4a2656f165d0 · Cited by 1
MESH1 functions as a metazoan PAPS phosphatase to regulate sulfation
Lin, C., Rose, J. S., Zhang, A., Mirando, A. J., Mestre, A. A., Ding, C. C., Liao, Y., Chen, S.-Y., Setayeshpour, Y., Wu, J., et al. (2026) · Nature Chemical Biology · doi:10.1038/s41589-026-02190-5 · Cited by 2
“Papss2 bm/bm mice exhibit shortened limbs, delayed epiphyseal ossification and impaired chondrocyte differentiation 10 .”
Mikami, T., & Kitagawa, H. (2026) · Springer eBooks · doi:10.1007/978-981-95-7386-8_61
Self-citationArylsulfatase L is a Golgi chondroitin sulfatase regulating skeletal development
Maddaluno, M., Leonibus, C. D., Prete, E. D., Salierno, F. G., Intartaglia, D., Carrella, D., Conte, I., Volpi, N., & Settembre, C. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113111
Nejati, P., Alimoradi, E., Molavi, F., Kamari, M., Ghafouri‐Fard, S., & Alibakhshi, R. (2026) · Human Gene · doi:10.1016/j.humgen.2026.201577
Jiang, S., Ying, X.-H., Wang, R., Zhang, Q., Chen, L., Shao, Z., & Li, J.-J. (2026) · Advanced Science · doi:10.1002/advs.77356
“Because CHST1 is classically defined as a carbohydrate sulfo-transferase, we generated a Chst1-R243Q mutant, a catalytically impaired mutant based on previous reports implicating this residue in sulfotransferase activity, to separate the enzymatic and non-catalytic functions of CHST1 [ 19, 20 ].”
New Syndromes First Reported Among Arabs
Teebi, A. S. (2010) · Springer eBooks · doi:10.1007/978-3-642-05080-0_7
Metadata
- Authors
- Thiele, H., Sakano, M., Kitagawa, H., Sugahara, K., Rajab, A., Höhne, W., Ritter, H., Leschik, G., Nürnberg, P., & Mundlos, S.
- Affiliations
- Institute of Medical Genetics and Institute of Biochemistry, Charité University Hospital, Humboldt University, Berlin 13353, Germany; Gene Mapping Center, Max Delbrück Center for Molecular Medicine, Berlin 13092, Germany; Department of Biochemistry, Kobe Pharmaceutical University, Higashinada, Kobe 658-8558, Japan; Genetic Unit, Directorate General of Health Affairs, Ministry of Health, 138 Muscat, Sultanate of Oman; and Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany
- Kobe Pharmaceutical University (JP)
- Corresponding author
- Mundlos, Stefan
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-06-23
- Volume
- 101
- Issue
- 27
- Pages
- 10155-10160
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC454181
- OpenAlex
- W2133789497
- Cited by
- 190
- References
- 28
- Citations by year
- 2026: 9 · 2025: 5 · 2024: 6 · 2023: 6 · 2022: 7 · 2021: 7 · 2020: 9 · 2019: 6 · 2018: 6 · 2017: 8 · 2016: 9 · 2015: 15 · 2014: 14 · 2013: 12 · 2012: 15
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- CHST3, chondrodysplasia, consanguineous family, chromosome 10q23, spinal involvement
- MeSH terms
- Carbohydrate Sulfotransferases, Binding Sites, Fibroblasts, Humans, Models, Biological, Osteochondrodysplasias, Spinal Diseases, Sulfotransferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.